VytlOne news and milestones

By Kim Tzoumakas, CEO, VytlOneOverviewHealth system pharmacy is one of the few growth levers a nonprofit or safety-net hospital fully controls, no new service line, payer negotia…

What is the Hospital Readmissions Reduction Program?HRRP is a value-based Medicare purchasing program that encourages hospitals to improve communication and care coordination to…

SummaryAs of August 26, 2026, there are 192 drug shortages according to the American Society of Health-System Pharmacists (ASHP). This is up slightly from 187 on May 20.Drug shor…

By Joel Wright, President, Pharmacy Services, VytlOneSummaryMost health systems capture only a fraction of the 340B savings they are eligible for. The gap hides in eligibility sc…

How VytlAIQ turns pharmacy data into decisionsBy Heather Brooks, Vice President, Pharmacy Services Products, VytlOneHow does AI improve pharmacy analytics for health systems? AI…

What is a pharmacy desert?A pharmacy desert is an area where residents lack reasonable access to a local pharmacy. Usually, this means when residents must travel long distances (…

Why AI Won't Replace PharmacistsBy Heather Brooks, Vice President, Pharmacy Services Products, VytlOneWill AI replace pharmacists? No. In health system pharmacy, AI is augmenting…

Frequently asked questions By Heather Brooks, Vice President, Pharmacy Services Products, VytlOneHow is AI improving the specialty pharmacy patient journey? AI is helping health…

5 Things Pharmacy Leaders Should Learn By Kim Tzoumakas, CEO, VytlOne Building AI in health system pharmacy means putting the operational foundation in place first and then using…

VytlOne has been named a 2026 Top Workplace by AZ Central, marking the sixth consecutive year the company has earned this distinction. The recognition is based entirely on employ…

VytlAIQ enables health care providers to optimize 340B performance, reduce referral leakage, scale pharmacy operations, and improve patient outcomes and experience through AI-ena…

VytlOne, the nation

Maxor Specialty Pharmacy, a VytlOne company, was selected by Insmed to be a limited distribution provider of Brinsupri. Brinsupri is a dipeptidyl peptidase 1 (DPP1) inhibitor ind…

/PRNewswire/ -- Maxor National Pharmacy Services ("Maxor") today announced its